Aim: Activation of PKR-like endoplasmic reticulum kinase (PERK), an endoplasmic reticulum stress sensor, is a feature of non-alcoholic steatohepatitis (NASH), yet regulators of PERK signaling remain undefined in this context. 
INTRODUCTION
T HE INCIDENCE OF obesity-associated non-alcoholic steatohepatitis (NASH) is rising worldwide, especially in the developed world, 1 leading to increased interest in understanding the pathophysiology of NASH, with an aim to determine therapeutic approaches to treat the disease. The molecular pathogenesis of NASH supports the view that lipotoxicity, the deleterious consequence of accumulated lipids in hepatocytes, plays a key role in disease development. 2 At a cellular and molecular level, lipotoxicity is associated with activation of the endoplasmic reticulum (ER) stress response in the liver; 3 however, a complete understanding of the role of ER stress signaling cascades during lipotoxicity is lacking. This is partly due to the complex nature of the ER stress response, wherein multiple divergent signaling pathways are activated simultaneously. 4, 5 Furthermore, although the canonical signaling cascades activated by the accumulation of unfolded proteins are well defined, there has been a recent expansion in our understanding of how individual components of the ER stress response machinery play disparate roles in obesity-associated disorders. 6, 7 Some of these proteins have pathophysiologic roles beyond the traditional unfolded protein response-activated signaling pathways, such as the role of X-box binding protein 1 (XBP1) in regulating hepatic lipogenesis 8 and bile acid metabolism. 9 The DnaJ family protein p58 IPK (DNAJC3) is an important modulator of the ER stress response protein PKR-like ER kinase (PERK) and cytosolic double-stranded RNAdependent protein kinase (PKR) signaling. 10, 11 P58 IPK is induced by ER stress and localizes to the ER lumen where a co-chaperone function has been described. 12 Additionally, p58
IPK has chaperone-independent and ER stressindependent functions in the regulation of cytosolic proteins. For example, it binds to the kinase domain of PKR, thus preventing its dimerization and activation. 13 
P58
IPK can also inhibit the additional eukaryotic translation initiation factor 2 α (eIF2α) kinase general control non-derepressible 2/eIF2α kinase 4 (GCN-2).
14 Thus, p58
IPK regulates several pathways potentially relevant in the pathogenesis of NASH; yet, the role of p58 IPK in NASH has not been examined. Its role in this process might be critical, given its high expression level in the liver. 15 Therefore, the objective of this study was to examine the contribution of p58
IPK to NASH in a dietary murine model. We used p58
IPK knockout (p58 ipkÀ/À ) mice, which have been previously described, 16 and a dietary model of NASH induced by ad libitum feeding of a diet high in fat, fructose, and cholesterol (FFC), as previously described by us. 17 We report that the activation of PERK was inhibited in FFC-fed p58 ipkÀ/À mouse livers, indicating that p58 IPK is necessary for PERK activation in this chronic dietary stress model. In addition, p58 ipkÀ/À mice are protected from hepatocyte apoptosis and liver injury. The reduction in liver injury is associated with a decrease in liver inflammation and consequent fibrosis. Thus, we conclude that p58 IPK mediates NASH, likely by promoting PERK activation which contributes to hepatocyte apoptosis and NASH pathogenesis.
METHODS

Animal studies
A LL ANIMAL USE was approved by the institutional care and animal use committee of the Mayo Clinic (Rochester, MN, USA) and carried out in accordance with the public health policy on the humane use and care of laboratory animals. Previously descried p58 IPK knockout mice (p58 ipkÀ/À ) were a gift from Dr. Katze, University of Washington. 16 Twelve-week-old male knockout mice and their wild-type (WT) littermate controls were fed either chow or a diet high in FFC for 20 weeks. This diet has been previously described by us and recapitulates many cardinal features of human NASH. 17 Overall, 14 mice were fed chow and 16 mice were fed the FFC diet. Out of 14 chow-fed mice, six were WT and eight were p58 ipkÀ/À ; of 16 FFC-fed mice, eight were WT and eight were p58 ipkÀ/À . Mice were co-housed in specific pathogen-free facilities and had unrestricted access to food and water. All the mice were on their respective diets for 20 weeks before they were killed. Total body weight was measured using a standard balance. Following death, blood was collected for serum alanine aminotransferase measurement. Liver was excised, weighed, and apportioned for downstream analyses, including RNA extraction, protein extraction, formalin fixation and paraffin embedding for histology, and cryosectioning.
Fasting blood glucose measurements
Mice were fasted for 8 h before measuring the blood glucose using a blood glucose meter (Assure 4; ARKRAY, Edina, MN, USA). Blood was collected from the tail vein and the strips provided in the kit were used to measure blood glucose.
Indirect calorimetry and physical activity
Oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ), and food intake were measured for 24 h under both fed and fasted conditions using a comprehensive laboratory animal monitoring system (CLAMS) equipped with an Oxymax Open Circuit Calorimeter (Columbus Instruments, Columbus, OH, USA) in four mice per group at week 16 of dietary feeding. We used VO 2 and VCO 2 to calculate energy expenditure (kcal/h/kg). The habitual physical activity of individual mice was measured in the horizontal (ambulation) and vertical (rearing) planes for a 48-h period in the CLAMS using photocells.
Biochemical assays and multimodal microscopy
Serum alanine aminotransferase (ALT) levels were measured using a commercially available veterinary scanner (Vet Scan 2; Abaxis, Union City, CA, USA). Cholesterol levels were measured using a commercially available assay (Cholesterol/Cholesteryl Ester Quantification Kit II, K623-100; BioVision, Milpitas, CA, USA). Cholesterol concentrations in high density lipoprotein (HDL) and low density lipoprotein/very low density lipoprotein (LDL/VLDL) were measured using a commercially available assay (EnzyChrom AF HDL and LDL/VLDL Assay Kit, E2HL-100; BioAssay Systems, Hayward, CA, USA) by colorimetric procedures. Coherent anti-Stokes Raman scattering (CARS) and second harmonic generation (SHG) microscopy were carried out on label-free liver cryosections (7 μm) imaged on a two-photon confocal microscope FluoView FV1000 MPE (Olympus America, Center Valley, PA, USA) using the CARS and SHG applications as previously described. 18 Images were obtained using an XLPlanN 25×/1.05w MP objective lens (Olympus America). For quantification, the areas of the CARS (neutral lipid) or SHG (collagen) signal with intensity above the threshold value were calculated using ImageJ (https://imagej.nih.gov/ij/).
Histological analyses
Liver tissues were fixed in neutral buffered formalin, embedded in paraffin, and sectioned. Standard hematoxylin-eosin-stained liver sections were graded according to the non-alcoholic fatty liver disease activity score. 19 Accumulation of extracellular matrix was quantified using Picro-Sirius red staining as previously described. 18 The positive areas were captured at 20× magnification on Nikon NIS elements advanced research imaging software attached to a Nikon Eclipse TE300 microscope (Nikon, Tokyo, Japan). Quantitative morphometry was carried out on the individual images for the Sirius red chromogen. Immunohistochemistry was undertaken following the standard protocol of the ABC Immunostaining Kit (Vector Laboratories, Burlingame, CA, USA). Briefly, slides were dewaxed using xylene and rehydrated through graded ethanol solutions. Antigen retrieval was carried out by heating slides to 95°C in 10 mM sodium citrate buffer (pH 6.0) for 30 min. Peroxidase, avidin, biotin, and non-specific binding sites in the tissue were blocked. Alpha smooth muscle actin (aSMA) antibody (ab124964; Abcam, Cambridge, UK) and F4/80 antibody (14-4801-82; eBioscience, Waltham, MA, USA) at 1:100 dilutions were applied to the tissue and incubated overnight in a humidified chamber at 4°C. After washing in phosphatebuffered saline (PBS), slides were incubated with biotinconjugated secondary antibody, streptavidin conjugated to horseradish peroxidase (HRP), and lastly chromogenic substrate according to the manufacturer's instructions (ABC; Vector Laboratories). Dehydrated sections were mounted using Permount mounting media (Sigma, St. Louis, MO, USA). The positive areas were captured at 20× magnification using the Nikon NIS-Elements advanced research imaging software attached to a Nikon Eclipse TE300 microscope or Zeiss Axio Scope A1 attached to an Axiocam 105 color camera (Carl Zeiss Microscopy, Thornwood, NY, USA). Images with uniform settings of magnification, light, and exposure time were used for quantitative image analysis. In Situ Cell Death Detection Kit Fluorescein (Roche, Indianapolis, IN, USA) was used to detect DNA strand breaks by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling method in paraformaldehydefixed 10-μM-thick liver cryosections according to the manufacturer's instructions. Nuclei were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI; Sigma), and quantified by averaging the number of apoptotic nuclei seen in 10 high power fields per sample.
Tunicamycin injection
Three pairs of age-matched WT and p58ipk À/À mice were weighed and injected with 2 mg/kg tunicamycin i.p. One pair of mice was euthanized 4 h after i.p. tunicamycin injection and two pairs were euthanized 6 h after i.p. tunicamycin injection. Liver tissue was collected as above.
Quantitative polymerase chain reaction
Total RNA was isolated from frozen liver tissue by homogenizing in TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) using a handheld homogenizer in 1 mL TRIzol per 15-20 mg liver tissue. Homogenate (300 μL) was transferred into a new 2-mL Eppendorf tube and 700 μL TRIzol and 1 mL of 100% ethyl alcohol was added.
This solution was applied to the RNA isolation column (Zymo-Spin IIC Column, Direct-zol RNA MiniPrep kit; Zymo Research, Irvine, CA, USA) in a collection tube (provided by the manufacturer in the Direct-zol RNA MiniPrep kit) and the RNA was extracted according to the manufacturer's instructions, including a DNase I treatment. RNA was quantified and assessed for quality using a Nano Drop ND1000 (Thermo Fisher Scientific). Reverse transcription was carried out with the iScript cDNA synthesis kit (BioRad Laboratories, Hercules, CA, USA). Quantitative realtime polymerase chain reactions (qPCR) were run on the Light Cycler 480 (Roche), using the Light Cycler 480 SYBR Green 1 Master Mix (Roche). Primers are summarized in Table 1 . Data are expressed relative to HPRT, which was used as the reference gene to normalize target genes of interest.
Western blot analysis
Liver tissue was homogenized in Tissue Protein Extraction Reagent (T-PER; Thermo Scientific). Equal amounts of protein were loaded onto Criterion Tris-HCl gels (Bio-Rad Laboratories) and electrotransferred to Immobilion-FL poly(vinylidene difluoride) membrane (EMD Millipore, Burlington, MA, USA). The membranes were blocked in either 5% non-fat dry milk or 5% bovine serum albumin in Tris-buffered saline-Tween 20, depending on the primary antibody manufacturer's recommendation, for 1 h at room temperature. Membranes were then incubated with the primary antibody overnight, followed by incubation with HRP-conjugated secondary antibodies for 1 h. Pierce ECL Western Blotting Substrate (ThermoFisher Scientific) was used to detect the HRP activity of the secondary antibodies 
Bone marrow-derived macrophage isolation and assays
Bone marrow-derived macrophages (BMDMs) were isolated from the hind bones of mice. Bone marrow was flushed out of the bones using HEPES balanced salt solution, dissociated by passing through a 25-gauge needle twice and plated in Petri dishes in RPMI containing 20% L929 cell-conditioned medium and 10% fetal bovine serum, and incubated at 37°C in 5% CO 2 . The BMDMs were dissociated after 7 days of differentiation using Accutase (Stemcell Technology, Cambridge, MA, USA).
Migration assays were carried out in modified Boyden chambers. Cells were pelleted at 1500 × g for 5 min at 4°C, resuspended in serum-free RPMI, and plated into 60-mm dishes in complete medium. Treatment media was made the next day using RPMI containing 2% FBS. Media was removed from the 60-mm dishes, cells were gently rinsed with PBS and 3 mL treatment media was placed on for 1 h as a pre-incubation step. Meanwhile, filters were evenly coated with 0.1% gelatin/PBS at room temperature for 25 min and dried for another 35 min. Cells were removed following the pre-incubation step, counted, and diluted to 2 500 000 cells/mL. Then 220 μL lipopolysaccharide (10 ng/mL) was placed at the bottom and cells on the top of the assembled chamber. Cells were allowed to migrate for 3 h, following which the excess cells and media were removed from the top chamber, and the chamber was disassembled to collect the filter papers. Filter papers were fixed in 10% formaldehyde for 30 min at room temperature, washed in PBS, and inverted with migrated cell side down on to a labelled glass slide with a drop of antifade gold with DAPI. Slides were left overnight to cure, then sealed and examined under confocal microscopy to count the number of migrated cells.
Data availability
All data generated or analyzed during this study are included in this published article.
Statistical and data analyses
Data are presented as mean ± standard error of the mean. Student's two-tailed t-test was used for comparing groups. Statistical analyses were undertaken in GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla, CA, USA). A P-value of <0.05 was considered significant.
RESULTS
Activation of PERK is attenuated in FFC-fed p58
ipkÀ/À mice W E FIRST ASSESSED the activation of PERK phosphorylation in p58 ipkÀ/À mouse livers in a dietary NASH model. We found that PERK was phosphorylated in FFC-fed WT mice; the lack of p58 IPK led to significant reduction in PERK phosphorylation (Fig. 1a) . In chow-fed and FFC-fed p58 ipkÀ/À mice, we noted an increase in eIF2α phosphorylation without an increase in PERK phosphorylation, implicating one of the other eIF2α kinases in its phosphorylation. Although there was an increase in eIF2α 
phosphorylation, we did not detect an increase in the levels of activating transcription factor 4 (ATF4), which is selectively translated following eIF2α phosphorylation, in FFC-fed p58 ipkÀ/À mice compared with FFC-fed WT mice. In fact, ATF4 expression was lower in FFC-fed p58 ipkÀ/À mice compared with FFC-fed WT mice. Similarly, the levels 
of C/EBP homologous protein (CHOP), which is downstream of ATF4, were lower in FFC-fed p58 ipkÀ/À mice compared with FFC-fed WT mice (Fig. 1b) ; the lower band is a well-recognized non-specific signal derived from CHOP antibodies. 20 Quantification of CHOP mRNA was consistent with the protein expression data (Fig. 1c) . C/EBP homologous protein mRNA expression was induced in FFC-fed WT mice; however, it was reduced in FFC-fed p58 ipkÀ/À mice. To confirm that the reduction in PERK phosphorylation was specific to chronic dietary stress, we induced acute pharmacologic ER stress in WT and p58 ipkÀ/À mice with i.p. tunicamycin injection. Following tunicamycin injection PERK phosphorylation was unchanged in p58 ipkÀ/À mice (Fig. 1d,e) , suggesting that the observed reduction in PERK phosphorylation was specific to this dietary NASH model.
Chronic dietary stress due to the FFC diet is known to activate the ER stress response in the liver; therefore, we tested whether there was differential activation of the inositol requiring enzyme 1α (IRE1α) and ATF6α pathways in the FFC-fed p58 ipkÀ/À mice in comparison to FFC-fed WT mice. Activation of IRE1α was assessed by splicing of its target mRNA, XBP1. Consistent with previous reports, FFC feeding led to a significant increase in XBP1 splicing (Fig. 2a) ; this was attenuated in the FFC-fed p58 ipkÀ/À mice. Expression of ATF6α target genes was similarly induced with FFC feeding in WT mice and remained attenuated in FFC-fed p58 ipkÀ/À mice (Fig. 2b,c) . These data suggest that FFC-fed p58 ipkÀ/À mice livers are resistant to dietinduced ER stress.
P58
ipkÀ/À mice are resistant to liver injury
The liver is a key target organ for dietary obesity-associated tissue injury. Therefore, we next examined the livers of FFC-fed WT and p58 ipkÀ/À mice for the development of NASH. Following 20 weeks of FFC feeding, the liver index (relative liver mass) of FFC-fed p58 ipkÀ/À mice showed hepatomegaly that was comparable to the relative liver mass of FFC-fed WT mice, and significantly greater than chow-fed p58 ipkÀ/À mice (Fig. 3a) . Interestingly, even chow-fed p58 ipkÀ/À mice showed hepatomegaly in comparison with chow-fed WT mice. Therefore, p58 ipkÀ/À mice develop significant hepatomegaly. We have previously reported that this dietary model of obesity-associated NASH is characterized by hepatocyte steatosis, hepatocyte ballooning, liver injury, inflammation, and activation of 17 Therefore, we next undertook histologic assessment of hepatic architecture after 20 weeks of FFC diet feeding. The results showed that the FFC-fed WT livers had features of NASH including steatosis, lobular inflammation, and fibrosis (Fig. 3b) . Liver of FFC-fed p58 ipkÀ/À mice appeared to have diminished hepatic steatosis on hematoxylineosin images (Fig. 3c) ; therefore, we undertook CARS microscopy for label-free quantification of the triglyceride content (Fig. 3c,d) . Consistent with the visual assessment of steatosis reduction, CARS-based quantification showed mild reduction in steatosis between the FFC-fed WT and p58 ipkÀ/À mice. Thus, the FFC-fed WT and p58 ipkÀ/À mice developed comparable hepatomegaly; there was mild reduction in steatosis in the p58 ipkÀ/À mice. Next, we looked at parameters of liver injury by measuring serum ALT, a marker of hepatocyte injury. Serum ALT was significantly elevated in WT mice fed the FFC diet for 20 weeks (Fig. 3e) . In contrast, FFC-fed p58 ipkÀ/À mice had significantly lower ALT values, reflecting lesser hepatocyte injury.
Hepatocyte apoptosis is reduced in FFC-fed p58 ipkÀ/À mice
Hepatocyte apoptosis is a key determinant of liver injury in NASH, therefore, we next asked if there was a concomitant reduction in apoptosis in the livers of FFC-fed p58 ipkÀ/À mice. We found that FFC feeding led to hepatocyte apoptosis in WT mice (Fig. 4a,b) . Apoptosis was significantly lower in FFC-fed p58 ipkÀ/À mice. The expression of the death receptors, tumor necrosis factor-related apoptosis- inducing ligand-receptor 2 (TRAIL-R2) and Fas, both of which are upregulated in NASH, were correspondingly increased by FFC feeding in WT mice (Fig. 4c,d) , and reduced in FFC-fed p58 ipkÀ/À mice. Thus, p58 IPK appears to mediate hepatocyte apoptosis in lipotoxicity. In its absence, hepatocyte apoptosis and liver injury are reduced.
Liver inflammation is reduced in p58 ipkÀ/À mice
Macrophage-mediated activation of the innate immune system is a key feature of liver injury in NASH and correlates with progressive disease. Therefore, we next examined hepatic macrophage accumulation using F4/80 immunohistochemistry. The FFC-fed WT mice showed significantly greater accumulation of F4/80-positive macrophages in the liver (Fig. 5a ). This was reduced in FFC-fed p58 ipkÀ/À mice. Corresponding quantification of F4/80 immunohistochemistry is shown in Figure 5 (b). There was a reduction in the mRNA abundance of markers of macrophage accumulation including F4/80 (Fig. 5c ) and CD68 (Fig. 5d) , and a reduction in the myeloid cell recruiting chemokine monocyte chemotactic protein 1 (MCP-1) (Fig. 5e ). Therefore, p58 ipkÀ/À mice show a reduction in liver inflammation compared to FFC-fed WT mice.
Hepatic fibrosis is reduced in p58 ipkÀ/À mice
Chronic liver injury and inflammation result in hepatic fibrosis. Therefore, we asked if the reduction in liver injury and inflammation in p58 ipkÀ/À mice was associated with a reduction in hepatic fibrosis. The expression of aSMA, a marker of activated hepatic stellate cells, was increased in FFC-fed WT mice in comparison with chow-fed WT and p58 ipkÀ/À mice (Fig. 6 ). However, aSMA expression was significantly lower in the FFC-fed p58 ipkÀ/À mice (Fig. 6a,c) . To complement the immunohistologic analysis we carried out second harmonic generation (SHG) microscopy for the quantification of collagen fibrils (Fig. 6b,d ). Second harmonic generation microscopy showed significant collagen deposition in FFC-fed WT livers, which was reduced in FFC-fed p58 ipkÀ/À liver, consistent with the aSMA immunohistochemistry. Furthermore, the mRNA expression of profibrogenic genes, such as collagen 1a1 and tissue inhibitor of metalloproteinases 1 (TIMP1), was in keeping with the histologic analyses (Fig. 6e,f) . Thus, hepatic fibrosis is reduced in FFC-fed p58 ipkÀ/À mice, a likely consequence of the reduction in liver injury and inflammation.
P58
ipkÀ/À mice are resistant to diet-induced obesity
ipkÀ/À mice were smaller than age-matched WT littermate controls at the start and completion of the feeding study (Fig. 7a,b) . When fed the FFC diet, WT mice gained weight; however, p58 ipkÀ/À mice remained resistant to weight gain, with terminal body mass of FFC-fed p58 ipkÀ/À mice comparable to chow-fed p58 ipkÀ/À mice (Fig. 7b) . The resistance to weight gain was not due to a reduction in food intake. In fact, FFC-fed p58 ipkÀ/À mice consumed more food than FFC-fed WT mice (Fig. 7c,d ). Greater food consumption is likely secondary to the known pancreatic beta cell failure with resultant diabetes in p58 ipkÀ/À mice, as previously reported. 16 The p58 ipkÀ/À mice had comparable fasting hyperglycemia regardless of diet (Fig. 7e) . Further characterization of the metabolic effects of FFC feeding showed comparable hypercholesterolemia in FFC-fed WT and p58 ipkÀ/À mice (Fig. 7f) , with corresponding increases in levels of HDL cholesterol and the LDL/VLDL cholesterol concentrations (Fig. 7g,h) . We next investigated differences in energy expenditure in these mice by indirect calorimetry. Resting and active energy expenditure was higher in FFC-fed p58 ipkÀ/À mice in comparison to FFC-fed WT mice (Fig. 8a,b) . Similarly, total energy expenditure was also higher in FFC-fed p58 ipkÀ/À mice in comparison to FFC-fed WT (Fig. 8c) . The respiratory exchange ratio was higher in the FFC-fed p58 ipkÀ/À mice (Fig. 8d) in the fasted state. Activity (Fig. 8e) , ambulation (Fig. 8f), and rearing (Fig. 8g) counts, all reflective of physical activity, were not statistically significantly different among groups. Thus, the FFC-fed p58 ipkÀ/À mice remain resistant to weight gain in spite of increased food intake, likely due to increased energy expenditure in comparison to FFC-fed WT mice. Furthermore, they showed profound fasting hyperglycemia. Both WT and p58 ipkÀ/À mice develop hypercholesterolemia following FFC feeding, consistent with the known effects of this diet.
Pro-inflammatory macrophage responses are intact in p58 ipkÀ/À mice
Due to the importance of macrophages in hepatic inflammation and fibrosis and our observation of reduced macrophage accumulation in FFC-fed p58 ipkÀ/À mice, we asked whether macrophage inflammatory responses were intact in p58 ipkÀ/À mice. To answer this we isolated BMDM from WT and p58 ipkÀ/À mice and examined their activation following treatment with lipopolysaccharide (LPS). We found that pro-inflammatory responses to LPS were not mitigated in p58 ipkÀ/À BMDM (Fig. 9a) . Similarly, macrophage migratory capacity was intact in p58 ipkÀ/À BMDM (Fig. 9b) ipkÀ/À mice; (ii) FFC-fed p58 ipkÀ/À mice are protected from hepatocyte apoptosis, liver injury, and inflammation; and (iii) macrophage pro-inflammatory and migratory responses are intact in the absence of p58 IPK . These data elucidate a novel role for p58 IPK in the pathogenesis of hepatocellular injury in dietary obesity-associated NASH.
The DnaJ family protein P58 IPK (DNAJC3) was identified as an ER stress-induced gene 10 in cells treated with the pharmacologic ER stress inducers tunicamycin or thapsigargin. Enforced overexpression of p58 IPK leads to inhibition of phosphorylation of eIF2α and reduced translation of ATF4. In isolated cells, overexpression of p58 IPK does not protect against ER stress-induced apoptosis; however, its silencing sensitizes cells to apoptosis. 12 Additional in vitro data have indicated that p58 IPK regulates the eIF2α kinases PERK, PKR, and GCN2 by inhibiting their phosphorylation. 14, 21 However, its role in vivo remains incompletely defined. P58
IPK is expressed in all tissues and its expression levels are known to be high in the pancreas and the liver. 15 Mice lacking p58 IPK develop glucosuria, hyperglycemia, and hypoinsulinemia due to apoptotic cell death of pancreatic islet cells; however, they are not insulin resistant. 16 In keeping with these observations, monogenic Four mice per group were assessed by a comprehensive laboratory animal monitoring system. *P < 0.05, **P < 0.05, ***P < 0.001. ns, not significant. p58 IPK mediates murine NASH 491 Hepatology Research 2018; 48: 479-494 type I diabetes is described in humans with homozygous DNAJC3 deletion. 22 However, the effects of p58 IPK loss have not been examined in the liver. Furthermore, its contribution to the pathogenesis of NASH is unknown.
Using a dietary model of NASH, we found that the FFC diet led to body weight gain in WT mice with concomitant hyperglycemia; however, p58 ipkÀ/À mice remained resistant to obesity in spite of greater food intake. This is likely due to the increased resting and active energy expenditure observed in p58 ipkÀ/À mice. The increase in energy expenditure is likely due to the known metabolic effects of type I diabetes, as reported by others; [23] [24] [25] resting energy expenditure and food-induced thermogenesis are both increased in type I diabetics, leading to tissue catabolism. However, the livers of p58 ipkÀ/À mice were not equally resistant to diet-induced steatosis. Indeed, the liver weight / body weight ratio of FFC-fed p58 ipkÀ/À mice was similar to that of FFC-fed WT mice. Unbiased quantification of liver fat showed only a mild reduction in liver fat content in FFCfed p58 ipkÀ/À mice. In contrast, we found a significant reduction in liver injury, inflammation, and consequent fibrosis in FFC-fed p58 ipkÀ/À mice. These data suggest a cell autonomous role for p58 IPK in promoting hepatocyte apoptosis and injury, as hepatocyte apoptosis is an important pathogenic event in NASH development. 26 Indeed, we found that the expression of death receptors TRAIL-R2 and Fas was reduced in FFC-fed p58 ipkÀ/À mice, as was hepatocyte apoptosis. The reduction in hepatocyte apoptosis may be a consequence of lower CHOP expression in the livers of FFC-fed p58 ipkÀ/À mice, and possibly increased energy expenditure with a minimal reduction in hepatic steatosis. This could be verified further with hepatocyte-specific conditional knockout mice; however, mice with a conditional deletion of p58 IPK have not yet been developed.
In the absence of conditionally deleted p58 IPK mice, we dissected the contribution of macrophages in our dietary model as macrophages are key mediators of the sterile inflammatory response that is a characteristic feature of liver injury and inflammation in NASH. 27 We noted a reduction in macrophage accumulation in the livers of FFC-fed p58 ipkÀ/À mice, in keeping with other pharmacologic and genetic models that showed a reduction in liver inflammation with amelioration of liver injury. 17, 18 The pro-inflammatory activation and migration responses of p58 ipkÀ/À BMDM toward LPS were intact, suggesting that hepatocyte p58
IPK was likely important in mediating hepatocyte injury. Therefore, the observed reduction in macrophage accumulation would be secondary to the reduction in liver injury. We also noted a reduction in hepatic fibrosis, a consequence of reduced injury and inflammation.
High-fat diet feeding is known to activate the ER stress pathways, including PERK signaling. 28 In keeping with the observations of other researchers, we found that FFC feeding activated PERK, as indicated by increased PERK phosphorylation. However, FFC-fed p58 ipkÀ/À mice showed a significant reduction in PERK phosphorylation. Although FFC feeding induced eIF2α phosphorylation, the levels of phosphorylated eIF2α were higher in the 
FFC-fed p58
ipkÀ/À mice than FFC-fed WT mice. This occurred in the absence of significant PERK phosphorylation, implicating one of the other eIF2α kinases in this process. Downstream of the phosphorylation of eIF2α, we did not observe an increase in ATF4 induction, in fact ATF4 expression was lower in FFC-fed p58 ipkÀ/À mice compared to WT mice. In keeping with this, CHOP protein expression and mRNA abundance was lower in FFC-fed p58 ipkÀ/À mice with respect to WT mice. Therefore, we conclude that, under chronic dietary stress conditions, FFC-fed p58 ipkÀ/À mice are resistant to activation of the ER stress pathways, including PERK phosphorylation and CHOP induction; the latter possibly mediates a reduction in hepatocyte apoptosis as observed in FFC-fed p58 ipkÀ/À mice. This is consistent with previous reports that the PERK/ATF4/CHOP pathway mediates palmitate-induced apoptosis in hepatocytes. 29 The lack of PERK phosphorylation in FFC-fed p58 ipkÀ/À suggests that there is a novel role for p58 IPK in maintaining PERK activation in chronic dietary stress. Although the regulation of eIF2α signaling downstream of PERK activation is well studied, the regulators of the proximal kinases remain undefined. In this regard, the molecular regulation of PERK levels, activation and dephosphorylation remain incompletely understood. Furthermore, although PERK knockout mice have been described, they uniformly experience neonatal lethality, precluding high-fat diet feeding. 30 We found that the in vivo reduction of PERK phosphorylation in the FFC-fed dietary model was distinct from the role of p58 IPK in pharmacologic ER stress, as p58 ipkÀ/À mice treated with tunicamycin showed unchanged PERK phosphorylation.
Thus, we conclude that p58 IPK promotes liver injury by PERK phosphorylation and activation under conditions of dietary stress. We have not elucidated how p58 IPK promotes PERK phosphorylation, such as stabilization of PERK protein dimers, and this will be an area for future studies. Our data also suggest that inhibition of hepatic p58 IPK may be a novel therapeutic target in NASH.
